, Tracking Stock Market Picks
Enter Symbol:
E.i. Du Pont De Nemours And Company (DD) [hlAlert]

down 13.80 %

E.i. Du Pont De Nemours And Company (DD) upgraded to Overweight with price target $67 by JP Morgan

Posted on: Wednesday,  Oct 23, 2013  8:25 AM ET by JP Morgan

JP Morgan rated Overweight E.i. Du Pont De Nemours And Company (NYSE: DD) on 10/23/2013, when the stock price was
$60.35. Since then, E.i. Du Pont De Nemours And Company has lost 13.80% as of 01/27/2016's recent price of $52.02.
If you would have followed this JP Morgan's recommendation on DD, you would have lost 13.8% of your investment in 826 days.

E.I. DuPont de Nemours is involved in science and technology in a range of disciplines including high-performance materials, specialty chemicals, pharmaceuticals and biotechnology. The company operates globally through strategic business units. Within the strategic business units, businesses manufacture and sell a wide range of products to many different markets, including the transportation, textile, construction, automotive, agricultural and hybrid seeds, nutrition and health, pharmaceuticals, packaging and electronics markets.

JPMorgan is a leading financial services firm with one of the largest client franchises in the world. We partner with our clients to offer the most complete and innovative solutions in the industry to help them achieve their goals. For more than 200 years, we have taken a long-term approach to our clients and to the way we conduct business. Our firm has grown considerably in scale and scope, but our commitment to our core principle of doing "only first-class business... in a first-class way" has never been stronger.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/23/2013 8:25 AM Buy
60.35 67.00
as of 12/13/2013
1 Week down  -1.79 %
1 Month down  -1.14 %
3 Months down  -0.18 %
1 YTD down  -0.18 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/24/2012 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy